Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations

Abstract

Our study provides evidence that GMP represents a promising dietary nutraceutical in view of its beneficial regulation of systemic insulin resistance and hepatic insulin signaling pathway, likely via its powerful antioxidant and anti-inflammatory properties.